VOLORIDGE INVESTMENT MANAGEMENT, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 200 filers reported holding SAGE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$4,668,030
-54.9%
429,837
-22.2%
0.02%
-55.3%
Q1 2024$10,356,492
+21.7%
552,641
+40.7%
0.04%
+11.8%
Q4 2023$8,509,787
+482.7%
392,699
+453.3%
0.03%
+385.7%
Q3 2023$1,460,521
-65.8%
70,968
-46.3%
0.01%
-68.2%
Q2 2022$4,267,000
+190.1%
132,101
+197.3%
0.02%
+175.0%
Q1 2022$1,471,000
-74.2%
44,440
-66.9%
0.01%
-74.2%
Q4 2021$5,711,000
-46.3%
134,245
-44.1%
0.03%
-55.1%
Q3 2021$10,644,000
+27.9%
240,207
+63.9%
0.07%
+19.0%
Q2 2021$8,325,000
-33.4%
146,546
-12.3%
0.06%
-36.3%
Q1 2021$12,504,000
-17.3%
167,059
-4.4%
0.09%
-28.3%
Q4 2020$15,113,000
+49.6%
174,699
+5.7%
0.13%
+51.2%
Q3 2020$10,100,000
-30.1%
165,247
-52.4%
0.08%
-49.1%
Q2 2020$14,443,000
+146.8%
347,353
+70.5%
0.16%
-1.8%
Q1 2020$5,851,000
+389.6%
203,712
+1130.8%
0.17%
+630.4%
Q4 2019$1,195,000
-51.4%
16,551
-5.6%
0.02%
-46.5%
Q3 2019$2,458,000
-72.3%
17,524
-67.5%
0.04%
-77.8%
Q4 2017$8,879,000
+50.7%
53,908
-27.1%
0.19%
+32.0%
Q2 2017$5,890,000
-0.6%
73,953
-11.3%
0.15%
+2.1%
Q1 2017$5,924,000
+130.8%
83,353
+65.8%
0.14%
+161.8%
Q4 2016$2,567,00050,2660.06%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 9,773,073$490,901,00052.36%
Ghost Tree Capital, LLC 240,000$12,056,0002.17%
EcoR1 Capital, LLC 112,455$5,649,0001.88%
New Leaf Venture Partners, L.L.C. 43,770$2,199,0001.49%
AlpInvest Partners B.V. 12,195$613,0001.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 595,443$29,909,0000.97%
APEX CAPITAL, LLC 190,000$9,544,0000.69%
OAK RIDGE INVESTMENTS LLC 385,770$19,377,0000.43%
Lombard Odier Asset Management (USA) Corp 92,089$4,626,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 65,724$3,301,0000.34%
View complete list of SAGE THERAPEUTICS INC shareholders